Invention Grant
US08765683B2 T-140 peptide analogs having CXCR4 super-agonist activity for cancer therapy
有权
具有CXCR4超激动剂活性用于癌症治疗的T-140肽类似物
- Patent Title: T-140 peptide analogs having CXCR4 super-agonist activity for cancer therapy
- Patent Title (中): 具有CXCR4超激动剂活性用于癌症治疗的T-140肽类似物
-
Application No.: US13360751Application Date: 2012-01-29
-
Publication No.: US08765683B2Publication Date: 2014-07-01
- Inventor: Amnon Peled , Michal Begin , Katia Beider , Michal Abraham
- Applicant: Amnon Peled , Michal Begin , Katia Beider , Michal Abraham
- Applicant Address: IL Nes Ziona
- Assignee: Biokine Therapeutics Ltd.
- Current Assignee: Biokine Therapeutics Ltd.
- Current Assignee Address: IL Nes Ziona
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61P35/00 ; A61K39/00 ; A61K38/10
Abstract:
The present invention is directed to novel therapeutic uses of T-140 analog peptides and compositions comprising same. Specifically, the invention provides compositions and methods useful in cancer therapy.
Public/Granted literature
- US20120207748A1 T-140 PEPTIDE ANALOGS HAVING CXCR4 SUPER-AGONIST ACTIVITY FOR CANCER THERAPY Public/Granted day:2012-08-16
Information query
IPC分类:
